Two Sigma Securities’s Halozyme HALO Stock Holding History

Two Sigma Securities’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,500	Closed	-$200K	–	2300
2024 Q3	$200K	Buy	+3,500	New	+$201K	﹤0.01%	2161
2020 Q1	–	Sell	-66,300	Closed	-$1.18M	–	1732
2019 Q4	$1.18M	Buy	66,300 +54,300	+453%	+$940K	0.01%	969
2019 Q3	$186K	Buy	12,000 +1,700	+17%	+$28K	﹤0.01%	1861
2019 Q2	$177K	Buy	+10,300	New	+$166K	﹤0.01%	1765

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Securities's HALO Position: Q3 2022 in Review

Two Sigma Securities sold out of Halozyme (HALO) in Q3 2022, closing a stake of 8,681 shares — an estimated $382K sold.

Two Sigma Securities first reported a position in HALO in Q2 2022 and held it in 1 quarter. The position peaked at $382K in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

Two Sigma Securities reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
Two Sigma Securities sold 8,681 Halozyme shares in Q3 2022, an estimated $382K.
Two Sigma Securities first reported a position in Halozyme in Q2 2022 and held it in 1 quarter.
Two Sigma Securities's Halozyme position peaked at $382K in Q2 2022.
357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.